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Abstract: Vitamin D insufficiency may be associated with increased risk of upper respiratory tract
infection (URTI) in athletes. This study examined the effects of vitamin D3 supplementation on
salivary immune functions and symptoms of URTI in vitamin D-insufficient taekwondo athletes.
Twenty-five male taekwondo athletes, aged 19–22 years with vitamin D insufficiency [serum
25-hydroxyvitamin-D concentrations (25(OH)D, 31.3 ± 1.39 nmol/L)], participated in this study.
They were randomized to receive 5000 IU/day of vitamin D3 (n = 13) or placebo capsule (n = 12)
during 4 weeks of winter training. Blood samples were collected two times (pre- and post-tests) for
analyzing serum 25(OH)D concentration while salivary samples were obtained three times (pre-,
mid-, and post-tests) for secretory immunoglobulin A (SIgA) and lactoferrin analyses. The symptoms
of URTI were reported daily during the intervention. Serum 25(OH)D concentration significantly
increased by 255.6% in the vitamin D group, whereas in the placebo group it did not change (p < 0.001).
While the significant increase in SIgA was observed in both groups (p < 0.001), elevated salivary
lactoferrin level in response to winter training was found only in the placebo group (p = 0.011).
The change in serum 25(OH)D concentration was negatively associated with total URTI symptoms
(r = −0.435, p = 0.015). Vitamin D3 supplementation may be effective in reducing the symptoms of
URTI during winter training in vitamin D-insufficient taekwondo athletes.
Keywords: high-intensity training; respiratory immune function; secretory immunoglobulin;
vitamin D

1. Introduction
Athletes of many sports participate in various training programs such as high-intensity interval
training, strength training, and conditioning training to improve their athletic performance [1,2].
Although high-intensity training provides performance benefits, there is a physiological challenge to
immune functions [3,4]. Traditionally, it has been recognized that participating in moderate-intensity
exercise comes with a lower risk of illness, whereas engaging in excessive volume of high-intensity
exercise suppresses the immune functions, thus the risk of illness is increased. This concept has been
introduced by Nieman known as ‘J-Curve’ [5]. The author pointed out that the intensity and volume
of exercise play important roles in modulating the immune functions.
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Upper respiratory tract infection (URTI) is the most common non-injury-related illness among
sports athletes, accounting for a 35%–65% incidence rate during high-intensity training or in
competition [6–8]. The acute URTI has been observed following heavy exercise in professional soccer
players [9], and high ventilation rates during high-intensity training has been known to contribute
to the exposure to bacterial and viral pathogens from the environment [10]. Additionally, prolonged
overtraining has shown to decrease respiratory immune functions [11]. It has been demonstrated
that the incidence of URTI was associated with reduced training load by 24% in endurance sports
athletes [12], and this insufficient training load may increase the injury rates and decrease the physical
capacity [13,14]. Besides, inadequate nutrition status during heavy exercise can impair the respiratory
immune functions [15]. Therefore, a well-designed training program with an adequate nutritional
supplementation is needed, not only to prevent the respiratory infections but also to optimize the
performance [16].
Recently, vitamin D3 supplementation has received wide attention in the athletic communities
because vitamin D deficiency or insufficiency is a prevalent issue among athletes such as swimmers [17],
football athletes [18], wrestlers [19], and taekwondo athletes [20]. Vitamin D deficiency has been
associated with low physical performance level as well as high susceptibility to URTI. There was a
negative linear association between vitamin D status and URTI in British adults [21], and vitamin
D-deficient athletes were more likely to present URTI symptoms than optimal vitamin D groups [12].
It has been recognized that vitamin D plays a vital role in modulating innate immune functions. Liu and
colleagues reported that the activation of toll-like receptors was linked with vitamin D-mediated
antimicrobial protein (AMP) production [22], and the concentration of AMPs, including secretory
immunoglobulin A (SIgA) and plasma cathelicidin, was positively associated with vitamin D status in
endurance sports athletes [12]. However, it is still debatable whether correcting vitamin D insufficiency
reduces URTI and improves salivary immune functions. Recently, meta-analysis studies have found
that vitamin D supplementation prevents the acute URTI [23,24], but the subjects in the selected
studies were primarily children or patients. We believe that lack of studies with sports athletes may
limit confirmation of the efficacy of vitamin D supplementation on URTI in the athletic communities.
Previous studies have found that while 14 weeks of vitamin D3 supplementation improve the resistance
to respiratory infections in athletes [25], adolescent swimmers did not reduce URTI following 12 weeks
of vitamin D3 supplementation [17].
Taekwondo athletes may be more likely to present low vitamin D levels, since the majority
of their training takes place indoors, therefore decreasing their sunlight exposure time. Also,
the weight category in sport may decrease the athletes’ vitamin D supplementation via food
intake [20]. Taekwondo athletes generally prepare for their upcoming season during the winter
period and training programs include various types of high-intensity interval training and endurance
training [2,26]. We believe that vitamin D insufficiency during winter training may negatively influence
the athletes’ respiratory immune functions. Therefore, this study examined the effects of vitamin D3
supplementation on salivary immune functions and URTI symptoms during winter training in vitamin
D-insufficient taekwondo athletes. It was hypothesized that four weeks of vitamin D3 supplementation
will increase serum 25(OH)D level. An increased serum 25(OH)D level will improve salivary immune
functions and symptoms of URTI in vitamin D-insufficient taekwondo athletes.
2. Methods
2.1. Participants
Twenty-six collegiate male taekwondo athletes, aged 19–22 years with vitamin D insufficiency
(<50 nmol/L), were initially enrolled in the study. Subjects regularly participated in both physical
and technical training five times a week, at least three hours per day. Before the study, subjects were
primarily screened with a questionnaire about their health status. The inclusion criteria of the study
were as follows: (a) healthy subject, (b) no skeletomuscular injuries, (c) no URTI episodes at least one
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week before the study, and (d) lower than 50 nmol/L of serum 25(OH)D concentration at baseline.
Any athletes who (a) were not willing to participate, (b) were taking any vitamin D3 supplement within
the last six months, and (c) had greater than 50 nmol/L of serum 25(OH)D concentration at baseline
were Int.
excluded.
After
of xinclusion and exclusion criteria, eligible subjects were 3randomly
J. Environ. Res.
Publicscreening
Health 2018, 15,
of 12
allocated to the vitamin D group (n = 13) and the placebo group (n = 13). However, one subject from
within the
lastcould
six months,
and (c) had
thanto50personal
nmol/L of
serum 25(OH)D
at
the placebo
group
not complete
the greater
study due
reasons,
therefore concentration
25 male taekwondo
baseline were excluded. After screening of inclusion and exclusion criteria, eligible subjects were
athletes (age: 19.9 ± 1.85 years, career: 99.8 ± 4.49 months, height: 181.7 ± 1.17 cm) completed this
randomly allocated to the vitamin D group (n = 13) and the placebo group (n = 13). However, one
study. Each subject signed a written consent form that had been approved by the Institutional Review
subject from the placebo group could not complete the study due to personal reasons, therefore 25
Boardmale
of the
University
(KHSIRB-15-025).
taekwondo
athletes
(age: 19.9 ± 1.85 years, career: 99.8 ± 4.49 months, height: 181.7 ± 1.17 cm)
completed this study. Each subject signed a written consent form that had been approved by the

2.2. Study
Design
Institutional Review Board of the University (KHSIRB-15-025).

This study was designed to be randomized, double-blinded, and placebo-controlled. The block
2.2. Study Design
randomization was applied based on serum 25(OH)D concentration. Participants’ serum 25(OH)D
This study
designedattobaseline
be randomized,
double-blinded,
and
The vitamin
block
concentrations
werewas
analyzed
to examine
the vitamin
D placebo-controlled.
status. In this study,
D
randomization
was
applied
based
on
serum
25(OH)D
concentration.
Participants’
serum
25(OH)D
insufficiency was defined as serum 25(OH)D level of 30–50 nmol/L [27]. All taekwondo athletes were
concentrations
were
baseline
to nmol/L).
examine the
vitamin
D status.
In were
this study,
vitamin
D
vitamin
D-insufficient
atanalyzed
baseline at
(31.3
± 1.39
Eligible
subjects
then
randomly
allocated
insufficiency was defined as serum 25(OH)D level of 30–50 nmol/L [27]. All taekwondo athletes were
to the vitamin D and placebo groups using block design with blocks of four or two to keep the group
vitamin D-insufficient at baseline (31.3 ± 1.39 nmol/L). Eligible subjects then were randomly allocated
sizes equal. They received daily either vitamin D3 (5000 IU) or a visually identical placebo capsule
to the vitamin D and placebo groups using block design with blocks of four or two to keep the group
(Bio-Tech
Fayettville,
AR,vitamin
USA) during
weeks
of winter
training.
The
treatment
sizes Pharmacal
equal. They Inc.,
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D3 (5000four
IU) or
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identical
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fashion
subjects,
coach,
and
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(Bio-Tech in
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AR,where
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of winter
training.remained
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actual
product
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where one
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coach,who
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3
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post-tests were performed three days before and after the intervention. Blood samples were collected
The preand
post-tests
wereto
performed
three days
before and
after the intervention.
Bloodsamples
samples were
two times
(preand
post-tests)
analyze serum
25(OH)D
concentration
while salivary
were
collected
two
times
(preand
post-tests)
to
analyze
serum
25(OH)D
concentration
while
salivary of
obtained three times (pre-, mid-, and post-tests) for SIgA and lactoferrin analyses. The symptoms
samples were obtained three times (pre-, mid-, and post-tests) for SIgA and lactoferrin analyses. The
URTI were daily reported by questionnaire during the intervention (Figure 1).
symptoms of URTI were daily reported by questionnaire during the intervention (Figure 1).

Figure 1. Study procedure note. HIIT: high intensity interval training, HICT: high intensity continuous
Figure 1. Study procedure note. HIIT: high intensity interval training, HICT: high intensity
training, SIgA: secretory immunoglobulin A, URTI: upper respiratory tract infection.
continuous training, SIgA: secretory immunoglobulin A, URTI: upper respiratory tract infection.

2.3. Physique and Body Composition

2.3. Physique and Body Composition

Subjects’
height and body weight were measured to the nearest 0.1 cm and 0.1 kg, respectively,
Subjects’ height and body weight were measured to the nearest 0.1 cm and 0.1 kg, respectively,
by using
a
stadiometer
(Takei,
T.K.K.,
calibratedscale
scale
(Seca
700,
Seca
GmbH,
Hamburg.,
by using a stadiometer
(Takei,
T.K.K.,Japan)
Japan)and
and aa calibrated
(Seca
700,
Seca
GmbH,
Hamburg.,
Germany).
BodyBody
composition
was was
assessed
by dual
X-rayX-ray
absorptiometry
(DXA,
QDR-4500W,
Hologic,
Germany).
composition
assessed
by dual
absorptiometry
(DXA,
QDR-4500W,
Marlborough,
MA, USA). MA,
Subjects
light
clothes
any metal
and removed
the the
jewelry
Hologic, Marlborough,
USA).wore
Subjects
wore
light without
clothes without
any metal
and removed
jewelry
attached
to their
body.
Then, were
subjects
weretoasked
to the
lie on
the table
DXA in
table
the supine
attached
to their
body.
Then,
subjects
asked
lie on
DXA
theinsupine
position
position
without anyAmovement.
A whole-body
DXA
scan was performed
for seven The
minutes.
without
any movement.
whole-body
DXA scan was
performed
for seven minutes.
DXAThe
analysis
DXA
analysis
was
performed
by
the
same-trained
technician.
The
intraclass
correlation
coefficients
was performed by the same-trained technician. The intraclass correlation coefficients (ICC) of DXA
(ICC) of DXA measurement was 0.99 in our laboratory [28]. Lean body mass (kg), fat mass (kg), and
body fat percentage (%) were reported in this study.
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measurement was 0.99 in our laboratory [28]. Lean body mass (kg), fat mass (kg), and body fat
percentage (%) were reported in this study.
2.4. Winter Training
Four weeks of winter training were conducted on the Jeju island in South Korea (latitude 33◦ 290 N).
The training program was designed based on previous studies, which included stretching, strength,
and conditioning, and technical training [2,26]. Briefly, subjects participated in three sessions of
training a day for five days a week. In the morning session (9:30 a.m.–11:30 am), subjects performed
high-intensity continuous running (>85% HRmax ) or high-intensity intermittent running (>90% HRmax )
on Monday, Wednesday, and Friday while they did resistance training on Tuesday and Thursday.
In the afternoon session (3:00 p.m.–5:00 p.m.), subjects performed various skill-related training such as
ladder drills and plyometric training. In the evening session (8:00 p.m.–9:00 p.m.), subjects performed
taekwondo training (i.e., basic kicking, sparring) or stretching. All subjects were asked to report their
rating of perceived exertion (RPE) with Borg’s scale (i.e., ‘6’ no exertion at all, ‘13’ somewhat hard,
‘20’ maximal exertion) at the end of the day to monitor daily perceived training intensity. All subjects
stayed in the same dormitory and a registered dietitian provided the meals during intervention.
2.5. Serum 25OH(D) Concentration Analysis
Blood samples were collected two times pre- and post-tests to analyze serum 25(OH)D
concentration. Blood sample collection was performed in the morning between 8:00 a.m. and
9:00 a.m. Subjects were asked to overnight fast and were prohibited from any severe physical
activity for 24 h before the test. When subjects arrived in the laboratory, they sat on the chair
quietly for 10 min. Then, venous blood samples (3 mL) were obtained from the antecubital vein
by a certified technician. The collected blood samples were clotted for ten minutes at room temperature
(20–22 ◦ C) and centrifuged at 3000 rpm for 15 min. The separated serum samples were stored at
80 ◦ C. An automatic chemiluminescent immunoassay (CLIA) analyzer (Liaison XL, Diasorin, Saluggia,
Italy) with Serum 25(OH)D kit (Liaison 25 OH vitamin Total, Diasorin, Saluggia, Italy) were used to
analyze serum 25(OH)D concentration. The variations of serum 25(OH)D analysis were less than 5%.
The laboratory participates in the International External Quality Assessment Scheme for Vitamin D
metabolites (DEQAS).
2.6. SIgA and Lactoferrin Analysis
Salivary samples were obtained three times in the morning between 8:00 a.m. and 9:00 a.m. at
pre-, mid- (2nd week), and post-tests to analyze the SIgA and lactoferrin concentrations. Subjects were
instructed not to drink any alcohol for 12 h with at least 3 h of fasting before the sample collection.
Subjects were prohibited from brushing their teeth one hour before the sample collection to prevent
any blood contamination. Prior to sample collection, subjects rinsed their mouth for 10 min with
cool water. Subjects then tilted their head slightly forward and provided salivary samples in the
conical tube (3 mL). While collecting the salivary samples, subjects were asked to minimize orofacial
movement. The collected samples were stored at −80 ◦ C. Enzyme-Linked Immunosorbent Assay
(ELISA) methods were used for analyzing SIgA and lactoferrin concentrations with salivary secretory
IgA indirect enzyme immunoassay kit (Salimetrics, Carlsbad, CA, USA) and human lactoferrine ELISA
kit (Biovendor, Brno, Czech Republic) by a microplate reader (VERSA Max Molecular device, San Jose,
CA, USA). The variations of SIgA and lactoferrin assays were less than 5%. Both blood and salivary
samples were analyzed at the certified research laboratory (Green cross lab cell, Yongin, Korea).
2.7. Upper Respiratory Tract Infection Symptoms
The symptoms of URTI were reported daily during four weeks of winter training. The Wisconsin
Upper Respiratory Symptom Survey-11 (WURSS-11) was used in this study. The questionnaire has
been validated in a previous study [29]. Briefly, the questionnaire included one overall URTI question,
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six URTI symptom questions, three quality of life (QOL) questions, and one overall URTI change
question. The URTI symptom represented the condition of nasal and throat, while QOL indicated the
condition of daily activities, thinking, and tiredness. The severity of URTI symptoms was rated on a
7-point Likert scale: 1 (very mild), 3 (mild), 5 (moderate), and 7 (severe). The URTI symptom score
was calculated by summing of six URTI symptom questions while the QOL score was calculated by
summing of three QOL questions during the study. The total URTI symptom is an overall condition
expressed by summing of URTI symptom and QOL scores [26]. In the present study, the average score
(sum of total score divided by the number of collecting day, score/day) of each variable was reported.
During the intervention period, eight subjects did not complete the questionnaires, so 17 questionnaires
(vitamin D, n = 8; placebo, n = 9) were used in the present study.
2.8. Statistical Analysis
Statistical analysis was performed by the SPSS software program (version 25, SPSS Inc., Chicago,
IL, USA). First, independent t-test was applied to examine the difference of baseline data between
the vitamin D and the placebo groups. Repeated measures of analysis of variances (ANOVAs) were
performed for all parametric variables to examine the interaction effects for group by time. If any
significant interaction or main effects were observed, paired t-test for 25(OH)D concentration or
Bonferroni post hoc test for salivary variables was performed. Mann-Whitney U test was applied
for nonparametric variables (i.e., URTI symptom, QOL, total URTI symptom) between the vitamin D
and the placebo groups. Kendall’s rank order correlation test was used to examine the correlations
between the absolute change in serum 25(OH)D concentration and total URTI symptom. All of the
data was presented by mean and standard error. Effect sizes (ESs) were reported by partial eta squared
(η p 2 ) [30]. The significance level was set at 0.05 in this study.
3. Results
3.1. Changes in Body Composition Variables
Table 1 presents the changes of body composition variables during winter training. There were no
significant differences in body composition variables between the vitamin D and the placebo groups at
baseline (p > 0.05). No significant interaction effects for group by time on body composition variables
were observed. However, there were significant time effects on body weight (p < 0.001, η p 2 = 0.486),
fat mass (p = 0.015, η p 2 = 0.023), and body fat percentage (p < 0.001, η p 2 = 0.634) where both groups
decreased significantly from pre- to post-tests.
Table 1. Changes in body composition variables during 4 weeks of winter training.
Variables
Body weight (kg)

Lean body mass (kg)

Fat mass (kg)

BFP (%)

Group

Pre

F-value

Post
G

T

G×T

1.788

27.768 *

2.080

3.147

1.011

1.257

0.086

6.916 *

0.000

0.237

39.894 *

0.106

+

Vitamin D

78.6 ± 3.28

76.7 ± 2.98

Placebo

72.5 ± 2.84

71.5 ± 2.77 +

Vitamin D

64.2 ± 2.12

64.1 ± 2.02

Placebo

58.7 ± 1.98

59.3 ± 2.02

Vitamin D

9.9 ± 1.19

9.3 ± 1.16 +

Placebo

9.5 ± 0.82

8.9 ± 0.67 +

Vitamin D

12.7 ± 0.99

11.8 ± 0.93 +

Placebo

13.4 ± 0.67

12.3 ± 0.55 +

Note. BFP, body fat percentage; G, group; T, time; G × T, group by time; * p < 0.05 indicates significant time effects.
p < 0.05 indicates significant changes from pre- to post-tests within the group.

+
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3.2. Change in Serum 25(OH)D Concentration
There was a significant interaction effect for group by time on serum 25(OH)D concentration
(F
=
253.316,
pRes.
<Public
0.001,
η p 22018,
=
.917).
Int.Int.
J. Environ.
Res.
Health
15,
6 of
J. Environ.
Public
Health
2018,
15,xxWhile the vitamin D group significantly increased serum 25(OH)D
6 of
12 12
concentration from 28.7 ± 1.51 to 100.1 ± 4.70 nmol/L, in the placebo group, it did not change
significantly
(PRE:
34.2
2.16and
andPOST:
POST:34.6
34.6 ±
1.66
nmol/L)
training.
Figure
2 shows
significantly
34.2
± ±2.16
±± 1.66
during
winter
training.
Figure
22 shows
significantly
(PRE:
34.2
±
2.16
and
POST:
1.66 nmol/L)
nmol/L)during
duringwinter
winter
training.
Figure
shows
individual
changesofofserum
serum25(OH)D
25(OH)Dconcentration
concentration from
the
individual
changes
from prethethe
individual
pre-to
topost-tests.
post-tests.

Figure
Individualchanges
changes of
of serum
serum 25(OH)D
25(OH)D concentration
Figure
2. 2.Individual
concentrationfrom
fromprepre-totopost-tests.
post-tests.* p* <p 0.05
< 0.05
indicates
a
significant
increase
from
preto
post-tests
in
the
vitamin
D
group.
Figure
2. aIndividual
serum
25(OH)D
concentration
from
pre- to post-tests. * p < 0.05
indicates
significantchanges
increase of
from
pre- to
post-tests
in the vitamin
D group.
indicates a significant increase from pre- to post-tests in the vitamin D group.
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ImmuneFunctions
Functions
3.3.3.3.
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ininSalivary

3.3. Changes
inshows
Immune
Functions
Figure
3Salivary
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nono
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Figure
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Therewere
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significant
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by
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and
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concentrations
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time
SIgA
and
lactoferrin
concentrations
(pwere
>However,
0.05).
However,
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3 effects
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the
changes
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There
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2 = 0.511)2and lactoferrin (F = 5.788, p = 0.011,
p
were
significant
time
effects
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SIgA
(F
=
23.0,
p
<
0.001,
η
there were effects
significant
time effects
= 23.0,
p < 0.001,
η p = 0.511) (p
and
lactoferrin
(F = 5.788,
interaction
for group
by timeononSIgA
SIgA(Fand
lactoferrin
concentrations
> 0.05).
However,
there
2 = 0.208).2 Bonferroni post hoc tests showed that while the significant increase in SIgA concentration
ηp0.011,
p
=
η
=
0.208).
Bonferroni
post
hoc
tests
showed
that
while
the
significant
increase
in
SIgA
2
p
were significant time effects on SIgA (F = 23.0, p < 0.001, ηp = 0.511) and lactoferrin (F = 5.788, p = 0.011,
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in observed
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elevatedthe
salivary
lactoferrin
level
in response
toresponse
winter training
concentration
was
in
both
elevated
salivary
lactoferrin
level
in
to
winter
2
ηp = 0.208). Bonferroni post hoc tests showed that while the significant increase in SIgA concentration
was found
inonly
the placebo
group. group.
training
was only
found
in the the
placebo
was
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in both
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elevated salivary lactoferrin level in response to winter training

was found only in the placebo group.

Figure 3. Changes in SIgA and lactoferrin concentrations. Note: * p < 0.05 indicates that SIgA
Figure 3. Changes in SIgA and lactoferrin concentrations. Note:
< 0.05 indicates that SIgA
concentration
increased in both groups from pre- to mid -tests, + p* <p0.05
indicates that lactoferrin
concentration increased in both groups from pre- to mid -tests, + p < 0.05 indicates that lactoferrin
concentration increased only in the placebo group from pre- to mid-tests.
concentration increased only in the placebo group from pre- to mid-tests.
Figure 3. Changes in SIgA and lactoferrin concentrations. Note: * p < 0.05 indicates that SIgA
concentration increased in both groups from pre- to mid -tests, + p < 0.05 indicates that lactoferrin
concentration increased only in the placebo group from pre- to mid-tests.
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3.4. Changes in URTI Symptoms
3.4. Changes in URTI Symptoms
Table 2 presents the difference of URTI symptoms between the vitamin D and placebo groups.
Table 2 presents the difference of URTI symptoms between the vitamin D and placebo groups.
There were significant differences in URTI symptoms (i.e., runny nose, sneezing, cough) and total
There were significant differences in URTI symptoms (i.e., runny nose, sneezing, cough) and total
URTI symptoms between the groups where the vitamin D group was lower than the placebo group.
URTI symptoms between the groups where the vitamin D group was lower than the placebo group.
However, the quality of life score (i.e., tiredness, daily activity) was not different between groups.
However, the quality of life score (i.e., tiredness, daily activity) was not different between groups.
The change in serum 25(OH)D concentration was negatively associated with total URTI symptoms
The change in serum 25(OH)D concentration was negatively associated with total URTI symptoms
during winter training. However, the significant correlations within each group were not observed in
during winter training. However, the significant correlations within each group were not observed
the study (Figure 4).
in the study (Figure 4).
Table 2. The symptoms of URTI during winter training.
Table 2. The symptoms of URTI during winter training.
Variables

Vitamin D
Placebo
Variables
Vitamin D
Placebo
URTI symptom
± ±1.60
URTI (score/day)
symptom (score/day)7.7 ± 1.06
7.7 ± 1.06 13.0
13.0
1.60
QOL (score/day)
7.0
±
1.00
9.7
±
QOL (score/day)
7.0 ±1.00
9.7 ±2.27
2.27
Total URTITotal
symptom
14.7 ± 1.64
± ±2.27
URTI(score/day)
symptom (score/day)
14.7 ± 1.64 22.7
22.7
2.27

U-value
p-value
U-value p-value
0.011
10.510.5 0.011
18.0
0.093
18.0
0.093
0.015
11.011.0 0.015
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4. Discussion
4. Discussion
The aim of this study was to examine the effects of vitamin D supplementation on salivary
The aim of this study was to examine the effects of vitamin D33 supplementation on salivary
immune functions and URTI symptoms in vitamin D-insufficient taekwondo athletes. Major findings
immune functions and URTI symptoms in vitamin D-insufficient taekwondo athletes. Major findings
of the study were that (1) daily dose of 5000 IU of vitamin D increased serum 25(OH)D level to a
of the study were that (1) daily dose of 5000 IU of vitamin D33 increased serum 25(OH)D level to a
sufficient level, (2) while the increase in SIgA concentration was observed in both groups, the elevated
sufficient level, (2) while the increase in SIgA concentration was observed in both groups, the elevated
salivary lactoferrin concentration in response to winter training was found only in the placebo group,
salivary lactoferrin concentration in response to winter training was found only in the placebo group,
and (3) the change in serum 25(OH)D concentration was negatively associated with total URTI
and (3) the change in serum 25(OH)D concentration was negatively associated with total URTI
symptoms during winter training in vitamin D-insufficient taekwondo athletes.
symptoms during winter training in vitamin D-insufficient taekwondo athletes.
4.1. Vitamin D Supplementation and Salivary Immune Functions
4.1. Vitamin D Supplementation and Salivary Immune Functions
Monitoring the AMPs, such as SIgA and lactoferrin, has been used as an indicator of URTI risk
Monitoring the AMPs, such as SIgA and lactoferrin, has been used as an indicator of URTI risk
among athletes [31]. The SIgA acts on protecting the body as an immunological barrier from viral
among athletes [31]. The SIgA acts on protecting the body as an immunological barrier from viral
pathogens and signaling the presence of antigens to phagocytes through the mucosal surfaces [32].
pathogens and signaling the presence of antigens to phagocytes through the mucosal surfaces [32].
In the present study, 4 weeks of vitamin D3 supplementation increased serum 25(OH)D concentration
In the present study, 4 weeks of vitamin D3 supplementation increased serum 25(OH)D concentration
to sufficient levels, but it did not improve the SIgA concentration where both groups increased
to sufficient levels, but it did not improve the SIgA concentration where both groups increased
significantly from pre- to mid-tests. A previous study reported that the increase in SIgA concentration
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significantly from pre- to mid-tests. A previous study reported that the increase in SIgA concentration
was observed after 4 weeks of intensified training in rhythmic gymnasts [33]. Another study supporting
our results showed that while a significant increase in serum 25(OH)D concentration was observed
from 54.5 to 125.5 nmol/L following 14 weeks of vitamin D3 supplementation (5000 IU/day), SIgA
concentration was not different between the vitamin D and the placebo groups in healthy adults [25].
However, the author found that vitamin D3 supplementation facilitates SIgA secretion rate as well
as salivary flow rate. Another study also reported that SIgA secretion rate was significantly higher
in the optimal vitamin D group than in individuals with vitamin D insufficiency or deficiency [12].
They assumed that the increase in SIgA secretion rate plays a vital role in improving the resistance to
respiratory infection. However, the present study did not measure the SIgA secretion rate and salivary
flow rate that may limit comparison of the results with previous studies.
Interestingly, the elevated salivary lactoferrin concentration in response to winter training was
found only in the placebo group in the present study. Salivary lactoferrin is one of the AMPs that
protect from respiratory infection, and it acts on the first line of defense against bacterial invasion from
the environment [34]. He and colleagues reported that vitamin D status was not associated with AMPs
concentrations such as lactoferrin, lysozyme, and SIgA [12], and correcting vitamin D level did not
affect salivary lactoferrin concentration during the winter period [25]. It remains unclear why the
lactoferrin level was increased only in the placebo group in the present study. It was assumed that the
increase in lactoferrin concentration may be associated with susceptibility to respiratory infections.
A greater salivary lactoferrin concentration has been observed following a single bout of cycling
exercise [35] and oral patients with chronic periodontitis showed higher lactoferrin concentration than
healthy adults [36].
4.2. Vitamin D3 Supplementation and URTI Symptoms
This study found that the vitamin D group was lower in URTI symptoms and total URTI symptoms
than the placebo group, and the change in serum 25(OH)D concentration was negatively correlated
with total URTI symptoms. Our findings were consistent with previous studies where vitamin D
supplementation reduced the incidence of URTI infection or symptom scores [24,37,38]. Vitamin D3
supplementation with a dosage of 4000 IU/day reduced 23% of infection scores in patients who
frequently had respiratory tract infections [37]. Another randomized and placebo-controlled study
reported that a dose of 300 IU/day of vitamin D3 during the winter period (i.e., from January to
March) reduced acute respiratory infections (odd ratio = 0.52) in vitamin D-deficient Mongolian
children [38]. A recent individualized meta-analysis study also supports our results, reporting that
vitamin D supplementation showed a 12% reduction in URTI [24].
As opposed to our results, three studies with athletes and young adults showed no effects of
vitamin D supplementation on URTIs [17,39,40]. Dubnov-Raz and colleagues found that twelve
weeks of vitamin D3 supplementation with a dosage of 2000 IU/day did not reduce the incidence
and severity of URTI in adolescent swimmers [17]. Laaksi et al. [39] also found that 6 months of
vitamin D3 supplementation did not change the number of days absent from military duty in young
Finnish men. Monthly doses of 100,000 IU of vitamin D3 in healthy adults did not reduce the incidence
or severity of URTIs in healthy adults [40]. However, there were interesting results in studies by
Durbnov-Ras and Lakki et al. where decreased serum 25(OH)D concentration during winter season
was negatively associated with the severity of URTIs in the placebo group [17], and the number
of days absent from duty was lower among military individuals who decreased serum 25(OH)D
concentration from 71.6 to 51.3 nmol/L during the winter season [39]. He and colleagues also pointed
out that athletes with low serum 25(OH)D status (<30 nmol/L) were more likely predisposed to
URTIs than athletes with greater than 120 nmol/L [12]. It is interesting that the benefits of vitamin D3
supplementation on URTI were not found in previous studies despite significant relations between
vitamin D and URTI. Our finding was the first evidence of vitamin D3 supplementation providing
a protective benefit against URTI symptoms among athletes. It was assumed that baseline vitamin
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D status might result in different outcomes between the previous and the present studies. In the
previous studies, baseline of vitamin D status was greater than 70 nmol/L [17,39] while our subjects
were 31.3 ± 1.39 nmol/L. Additionally, small changes in serum 25(OH)D concentration (16.9 nmol/L
increase in swimmers and 2.l nmol/L decrease in young healthy adults vs. 71.4 nmol/L increase in
taekwondo athletes) as well as low vitamin D3 dosage (2000 and 400 IU/day vs. 5000 IU/day) may
affect the different results on URTIs. A recent meta-analysis study also supports our assumption that a
great benefit of vitamin D supplementation on URTIs was found among individuals with low baseline
25(OH)D level (<25 nmol/L, odds ratio = 0.58) [24]. The author also described that daily or weekly
vitamin D supplementation was more beneficial than a bolus dose to reduce the acute respiratory
tract infection [24]. Other factors such as race, treatment periods, training intensity, and individual
sensitivities to URTIs may influence the different outcomes. Nevertheless, our study confirmed that
a daily dose of 5000 IU of vitamin D3 reduces URTI symptoms in vitamin D-insufficient taekwondo
male athletes.
5. Limitation of Study
There are some limitations in the present study that should be considered when interpreting
the results. Although the present study was designed systematically with a randomized controlled
trial, small sample sizes may limit confirming the effectiveness of vitamin D3 supplementation on
URTIs in athletes. An adequate number of subjects may be required in future studies to approach
the clinical practice. Recruiting only male athletes also limits confirming the benefits of vitamin D3
supplementation in female athletes. Secondly, the Diasorin method can underestimate the serum
25(OH)D level compared to standardized assay such as LC-MS/MS [41,42]. However, this method
has become the most popular assay in hospital and clinical laboratories, and it is an important tool
for assessing an individual’s vitamin D level [43,44]. In addition, a previous study reported that the
correlation between Diasorin and LC-MS/MS reflected more precisely at lower 25(OH)D concentration
ranges [42]. We believe that Diasorin assay is suitable for the current study as we aimed to examine
Vitamin D3 supplementation effects on URTI in the athletes who are considered as having Vitamin D
insufficiency. Third, even though the present study used a smaller number of questions (11 questions)
compared to other studies using questionnaires (i.e., 44 and 21 questions) [10,45] to increase the
completion rate, the number of participants who completed the URTI questionnaire were only 17
subjects. It is assumed that lack of motivation with the questionnaire may decrease the returning rate
despite the encouragement by coach and evaluators. A previous study with adolescent swimmers also
reported low returning rate, indicating only 22 subjects (vitamin D group, n = 11, Placebo group, n = 11)
completed the URTI questionnaire out of a total 55 subjects (vitamin D group, n = 28, placebo group,
n = 27) [17]. Finally, the definition of URTI symptoms can be varied based on laboratory measurement,
self-reported colds, and different questionnaires. Although clinically evaluated URTI episodes provide
accurate information of true infections [46], the URTI symptoms evaluated by questionnaire should
not be dismissed to identify the perceived conditions.
6. Conclusions
The present randomized controlled trial revealed that a daily dose of 5000 IU of vitamin D3
increases serum 25(OH)D concentration to a sufficient level, and the increased serum 25(OH)D level
reduces the URTI symptoms following four weeks of winter training in vitamin D-insufficient male
taekwondo athletes. Vitamin D3 supplementation may be effective in reducing the symptoms of URTI
during winter training in vitamin D-insufficient taekwondo athletes.
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